- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 03.11. | Madrigal's Rezdiffra storms past blockbuster milestone as CEO hails 'accelerating' MASH market | ||
| 03.11. | Pfizer delivers Q3 beat as post-COVID comeback gains momentum | ||
| 03.11. | As Bayer spots pharma recovery, questions resurface over potential crop science split | ||
| 03.11. | Lonza bets big on US growth, snaps up Merck KGaA's CDMO business | ||
| 02.11. | Sumitomo's Gemtesa power couple takes the wheel in road-trip themed overactive bladder awareness push | ||
| 02.11. | Hansoh, Samsung Biologics hit with FDA write-ups after inspections | ||
| 02.11. | Inovio's DNA-based immunotherapy Voceryq approved by FDA for rare HPV airway disease | ||
| 02.11. | Karyopharm files Chapter 11, lines up Ayrmid as lead bidder in planned merger | ||
| 02.11. | Dexcom taps celebrities, influencers for 'A Letter to Diabetes' campaign | ||
| 02.11. | Compass points to unmet need in depression as landmark psychedelic nears market | ||
| 02.11. | Fresenius strikes WuXi biosimilars deal for up to 37 assets, targeting €370B market | ||
| 02.11. | Sanofi tips Dupixent to reap most rewards from Eli Lilly's Ebglyss ad push | ||
| 30.10. | As Skyrizi and Rinvoq dominate AbbVie's Q3, analysts ask what's next | ||
| 30.10. | Proof Over Promise: What a DTP Program Actually Looks Like When It's Working | ||
| 30.10. | As Dupixent keeps sales churning, Sanofi doubles down on R&D re-work | ||
| 30.10. | AstraZeneca launches $1.5B savings plan to fuel pipeline growth, says workforce won't shrink | ||
| 30.10. | Pfizer looks to reroute supply after flooding sidelined India injectables plant | ||
| 30.10. | Fierce Pharma Asia-The hunt for Enhertu's successor; ESMO data from Merck, BMS, Takeda and more | ||
| 29.10. | Lenz reports 75% workforce cut, CEO shakeup alongside Q3 earnings update | ||
| 29.10. | Lilly breaks down Medicare Bridge boon as GLP-1 sales drive another guidance lift | ||
| 29.10. | Women 'still waiting' for healthcare to earn their trust: report | ||
| 29.10. | AZ takes a 'time out' with former teen TV star in biomarker testing push | ||
| 29.10. | HCPs Aren't Ignoring Your Science. They're Ignoring How (and When) You Deliver It | ||
| 29.10. | Merck outlines 2027 as 'another year of investment' despite recent clinical wins | ||
| 29.10. | Bristol Myers' Cobenfy performance called into question amid overall Q3 revenue beat |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.